BPC-157 is one of the most discussed peptides on the wellness internet and one of the least documented in the human clinical literature, and the gap between those two facts is where most of its safety story sits
In some embodiments, the otic formulation or composition contains at least one viscosity modulating agent that provides the otic formulation or composition with a viscosity of at least about 10 cP, about 20 cP, about 30 cP, about 40 cP, about 50 cP, about 60 cP, about 70 cP, about 80 cP, about 90 cP, about 100 cP, about 200 cP, about 300 cP, about 400 cP, about 500 cP, about 600 cP, about 700 cP, about 800 cP, about 900 cP, about 1000 cP, about 2,000 cP, about 3,000 cP, about 4,000 cP, about 5,000 cP, about 6,000 cP, about 7,000 cP, about 8,000 cP, about 9,000 cP, about 10,000 cP, about 15,000 cP, or about 20,000 cP
A 2025 systematic review of BPC-157 in orthopedic applications confirmed improved structural, functional, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries in 36 studies
This small molecule, known scientifically as 5-amino-1-methylquinolinium , works by blocking an enzyme called NNMT (nicotinamide N-methyltransferase), which plays a key role in fat storage
